Sex-independent neuroprotection with minocycline after experimental thromboembolic stroke

[1]  J. Switzer,et al.  Matrix Metalloproteinase-9 in an Exploratory Trial of Intravenous Minocycline for Acute Ischemic Stroke , 2011, Stroke.

[2]  Fudong Liu,et al.  Middle Cerebral Artery Occlusion Model in Rodents: Methods and Potential Pitfalls , 2011, Journal of biomedicine & biotechnology.

[3]  J. Switzer,et al.  Minocycline to Improve Neurologic Outcome in Stroke (MINOS): A Dose-Finding Study , 2010, Stroke.

[4]  A. Ergul,et al.  Endothelin-1-mediated cerebrovascular remodeling is not associated with increased ischemic brain injury in diabetes. , 2010, Canadian journal of physiology and pharmacology.

[5]  C. Sobey,et al.  Mechanisms Contributing to Cerebral Infarct Size after Stroke: Gender, Reperfusion, T Lymphocytes, and Nox2-Derived Superoxide , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  Susan C Fagan,et al.  Minocycline and Tissue-Type Plasminogen Activator for Stroke: Assessment of Interaction Potential , 2009, Stroke.

[7]  Marc Fisher,et al.  Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations , 2009, Stroke.

[8]  Jun Li,et al.  Sex differences in caspase activation after stroke. , 2009, Stroke.

[9]  L. McCullough,et al.  Sex Differences in Minocycline-Induced Neuroprotection after Experimental Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  K. Rhodes,et al.  Extension of the Thrombolytic Time Window With Minocycline in Experimental Stroke , 2008, Stroke.

[11]  K. Kurachi,et al.  Age-related effects of regular physical activity on hemostatic factors in men , 2008, Journal of Thrombosis and Thrombolysis.

[12]  W. Schäbitz,et al.  MINOCYCLINE TREATMENT IN ACUTE STROKE: AN OPEN-LABEL, EVALUATOR-BLINDED STUDY , 2007, Neurology.

[13]  J. Switzer,et al.  Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes , 2007, BMC neurology.

[14]  D. Hess,et al.  Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke , 2006, BMC Neuroscience.

[15]  C. Rosen,et al.  Selective MCA occlusion: A precise embolic stroke model , 2006, Journal of Neuroscience Methods.

[16]  R. Swanson,et al.  Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Rona G. Giffard,et al.  Microglia Potentiate Damage to Blood–Brain Barrier Constituents: Improvement by Minocycline In Vivo and In Vitro , 2006, Stroke.

[18]  R. Koehler,et al.  Neuroprotective Effect of Selective Kappa Opioid Receptor Agonist is Gender Specific and Linked to Reduced Neuronal Nitric Oxide , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  G. Schlaug,et al.  Arterial Occlusive Lesions Recanalize More Frequently in Women Than in Men After Intravenous Tissue Plasminogen Activator Administration for Acute Stroke , 2005, Stroke.

[20]  L. McCullough,et al.  Ischemic Nitric Oxide and Poly (ADP-Ribose) Polymerase-1 in Cerebral Ischemia: Male Toxicity, Female Protection , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  D. Hess,et al.  Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats , 2004, BMC neurology.

[22]  Alex Rovira,et al.  Plasmatic Level of Neuroinflammatory Markers Predict the Extent of Diffusion-Weighted Image Lesions in Hyperacute Stroke , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  J. Koziol,et al.  Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. , 2003, Stroke.

[24]  Kyung-Yul Lee,et al.  Increase in Plasma Matrix Metalloproteinase-9 in Acute Stroke Patients With Thrombolysis Failure , 2003, Stroke.

[25]  Jean-Pierre Julien,et al.  Efficient three‐drug cocktail for disease induced by mutant superoxide dismutase , 2003, Annals of neurology.

[26]  J. Arenillas,et al.  Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke , 2003, Circulation.

[27]  M. Chopp,et al.  Inhibition of Factor Xa Reduces Ischemic Brain Damage After Thromboembolic Stroke in Rats , 2003, Stroke.

[28]  E. Lo,et al.  Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9 Expression During Reperfusion Injury: Mechanical Versus Embolic Focal Ischemia in Spontaneously Hypertensive Rats , 2002, Stroke.

[29]  Tao Yang,et al.  Delayed minocycline but not delayed mild hypothermia protects against embolic stroke , 2002, BMC neurology.

[30]  J. Arenillas,et al.  Matrix Metalloproteinase Expression Is Related to Hemorrhagic Transformation After Cardioembolic Stroke , 2001, Stroke.

[31]  P. Chan,et al.  A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Roda,et al.  [Treatment of embolic cerebral infarct via thrombolysis and cytoprotection with U-74389-G in rats]. , 1998, Revista de neurologia.

[33]  G. Zoppo.  Clinical trials in acute stroke: why have they not been successful? , 1998 .

[34]  Patricia H. Petrozza,et al.  Gender-linked brain injury in experimental stroke , 1998 .

[35]  M. Chopp,et al.  A Mouse Model of Embolic Focal Cerebral Ischemia , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  M. Chopp,et al.  A New Rat Model of Thrombotic Focal Cerebral Ischemia , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[37]  R. Stout,et al.  Seasonal changes in haemostatic factors in young and elderly subjects. , 1996, Age and ageing.

[38]  C. Finch,et al.  A longitudinal study of estrous cyclicity in aging C57BL/6J mice: I. Cycle frequency, length and vaginal cytology. , 1982, Biology of reproduction.

[39]  H. Winn,et al.  RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION). , 2009, Journal of experimental stroke & translational medicine.

[40]  K. Sicard,et al.  Experimental & Translational Stroke Medicine , 2009 .

[41]  R. Traystman,et al.  Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. , 2000, Stroke.

[42]  R. Traystman,et al.  Gender-linked brain injury in experimental stroke. , 1998, Stroke.

[43]  C. Bean,et al.  A study of the fibrinolytic response in healthy men and women following a brief exposure to venous occlusion. , 1996, Thrombosis research.